SCHEMBL6180576

SCHEMBL6180576

O=P(O)(O)C1CCNC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1899438 0.86 SLC6A1 (0.43)
SCHEMBL7451085 0.84 GABRA1 (0.40)
SCHEMBL28496040 0.78 MAN1B1 (0.35)
SCHEMBL19544697 0.75
Phosphoric Acid SCHEMBL28329151 0.70 SLC6A1 (0.35)
SCHEMBL6677874 0.70 TSHR (0.37)
SCHEMBL4954695 0.68
SCHEMBL19212088 0.68 GRM4 (0.39)
SCHEMBL25175677 0.65 INPP5A (0.44)
SCHEMBL22479135 0.65 INPP5A (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104812766-A Method for synthesis of aminoalkylenephosphonic acid STRAITMARK HOLDING AG 2015-07-29 CN disclosed
EP-1470137-A4 EDG RECEPTOR AGONISTS MERCK & CO INC (US) 2005-06-15 EP disclosed
EP-1470137-A1 EDG RECEPTOR AGONISTS Merck & Co., Inc. (US) 2004-10-27 EP disclosed
WO-2003062252-A1 EDG RECEPTOR AGONISTS MERCK & CO., INC. (US) 2003-07-31 WO disclosed
US-5470844-A Heterocyclic-NMDA antagonists MERRELL DOW PHARMACEUTICALS INC. (US) 1995-11-28 US disclosed